CENDR PLATFORM Trademark

Trademark Overview

On Friday, August 28, 2020, a trademark application was filed for CENDR PLATFORM with the United States Patent and Trademark Office. The USPTO has given the CENDR PLATFORM trademark a serial number of 90144106. The federal status of this trademark filing is REGISTERED as of Tuesday, May 2, 2023. This trademark is owned by Cend Therapeutics Inc.. The CENDR PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research information in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors; laboratory research services in the field of oncology for both solid and liquid tumors
cendr platform

General Information

Serial Number90144106
Word MarkCENDR PLATFORM
Filing DateFriday, August 28, 2020
Status700 - REGISTERED
Status DateTuesday, May 2, 2023
Registration Number7043544
Registration DateTuesday, May 2, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Disclaimer with Predetermined Text"PLATFORM"
Goods and ServicesMedical and scientific research information in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors; laboratory research services in the field of oncology for both solid and liquid tumors

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 1, 2020
Primary Code042
First Use Anywhere DateMonday, August 31, 2020
First Use In Commerce DateMonday, August 31, 2020

Trademark Owner History

Party NameCend Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameCend Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameCend Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, May 2, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 2, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 28, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 4, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 14, 2023USE AMENDMENT FILED
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 14, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 1 GRANTED
Tuesday, August 9, 2022SOU EXTENSION 1 FILED
Tuesday, August 9, 2022TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, November 12, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, November 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 3, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 1, 2021ASSIGNED TO LIE
Wednesday, October 27, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 22, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 22, 2021FINAL REFUSAL E-MAILED
Tuesday, June 22, 2021FINAL REFUSAL WRITTEN
Saturday, May 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 14, 2021NON-FINAL ACTION E-MAILED
Thursday, January 14, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 30, 2020ASSIGNED TO EXAMINER
Thursday, October 1, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 1, 2020NEW APPLICATION ENTERED

Related Keywords

platform cendr field solid medical both liquid tumors research oncology services laboratory